Glaukos GKOS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Corneal Health | $89.16M+3.2% | $86.37M+3.1% | $83.76M+3.3% | $81.11M+1.0% | $80.33M+0.2% | |
| Glaucoma | $462.19M+9.8% | $421.07M+9.1% | $386.06M+9.7% | $351.85M+8.5% | $324.19M+6.9% | |
| Revenue by Geography | ||||||
| Non Us | $139.03M+5.0% | $132.4M+4.1% | $127.21M+4.5% | $121.78M+4.0% | $117.05M+3.2% | |
| US | $412.32M+9.9% | $375.04M+9.5% | $342.61M+10.1% | $311.18M+8.2% | $287.48M+6.4% | |
| PP&E (Net) by Geography | ||||||
| Non Us | $845K+13.9% | $742K+8.5% | $684K— | —— | —— | |
| US | $447.6M+3.6% | $432.08M+3.7% | $416.75M— | —— | —— | |
| Capital Expenditure by Geography | ||||||
| Non Us | $189K+90.9% | $99K— | —— | —— | —— | |
| US | $9.5M+25.5% | $7.57M+18.5% | $6.38M+3.1% | $6.19M-13.7% | $7.18M+15.2% | |
| D&A by Geography | ||||||
| Non Us | $49K-2.0% | $50K+6.4% | $47K+6.8% | $44K+12.8% | $39K+11.4% | |
| US | $41.61M+9.4% | $38.04M+9.9% | $34.62M+0.4% | $34.49M-1.2% | $34.93M-1.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Glaukos break its business down?
- Glaukos (GKOS) reports revenue by product across 2 parts — Corneal Health and Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Glaukos's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Glaukos's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
